Agreement is poor among current criteria used to define response to cardiac resynchronization therapy

Circulation

Volumn 121, Issue 18, 2010, Pages 1985-1991

  Fornwalt, Brandon K ^a,b   Sprague, William W ^a   Bedell, Patrick ^c   Suever, Jonathan D ^b   Gerritse, Bart ^d   Merlino, John D ^a,c   Fyfe, Derek A ^a,e   León, Angel R ^a,c   Oshinski, John N ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c Carlyle Fraser Heart Center   (United States)

^d MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

^e SIBLEY HEART CENTER CARDIOLOGY   (United States)

Author keywords

Cardiac resynchronization therapy; Heart failure; Pacemakers; Pacing

Indexed keywords

ARTICLE; CALCULATION; CARDIAC RESYNCHRONIZATION THERAPY; CITATION ANALYSIS; ECHOCARDIOGRAPHY; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; POPULATION; PREDICTION; PRIORITY JOURNAL; PUBLICATION; TREATMENT RESPONSE;

CARDIAC PACING, ARTIFICIAL; HEART FAILURE; HUMANS; MODELS, STATISTICAL; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS;

EID: 77952237391     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.910778     Document Type: Article

References (34)

1. Bax JJ, Marwick TH, Molhoek SG, Bleeker GB, van Erven L, Boersma E, Steendijk P, van der Wall EE, Schalij MJ. Left ventricular dyssyn-chrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol. 2003;92:1238-1240.
2. Bleeker GB, Bax JJ, Fung JWH, van der Wall EE, Zhang Q, Schalij MJ, Chan JYS, Yu CM. Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. Am J Cardiol. 2006;97:260-263.
3. Gorcsan J, Tanabe M, Bleeker GB, Suffoletto MS, Thomas NC, Saba S, Tops LF, Schalij MJ, Bax JJ. Combined longitudinal and radial dyssyn-chrony predicts ventricular response after resynchronization therapy. J Am Coll Cardiol. 2007;50:1476-1483.
4. Suffoletto MS, Dohi K, Cannesson M, Saba S, Gorcsan J. Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resyn-chronization therapy. Circulation. 2006;113:960-968.
5. Notabartolo D, Merlino JD, Smith AL, DeLurgio DB, Vera FV, Easley KA, Martin RP, Leon AR. Usefulness of the peak velocity difference by tissue Doppler imaging technique as an effective predictor of response to cardiac resynchronization therapy. Am J Cardiol. 2004;94:817-820.
6. Yu CM, Chan YS, Zhang Q, Yip GWK, Chan CK, Kum LCC, Wu L, Lee APW, Lam YY, Fung JWH. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol. 2006;48:2251-2257.
7. Yu CM, Fung JWH, Chan CK, Chan YS, Zhang Q, Lin H, Yip GWK, Kum LCC, Kong SL, Zhang Y, Sanderson JE. Comparison of efficacy of reverse remodeling and clinical improvement for relatively narrow and wide QRS complexes after cardiac resynchronization therapy for heart failure. J Cardiovasc Electrophysiol. 2004;15:1058-1065.
8. Yu CM, Zhang Q, Chan YS, Chan CK, Yip GWK, Kum LCC, Wu EB, Lee PW, Lam YY, Chan S, Fung JWH. Tissue Doppler velocity is superior to displacement and strain mapping in predicting left ventricular reverse remodelling response after cardiac resynchronisation therapy. Heart. 2006;92:1452-1456.
9. Yu CM, Zhang Q, Fung JWH, Chan HCK, Chan YS, Yip GWK, Kong SL, Lin H, Zhang Y, Sanderson JE. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging. J Am Coll Cardiol. 2005;45:677-684.
10. Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsan J, Sutton MS, De Sutter J, Murillo J. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008;117:2608-2616.
11. Diaz-Infante E, Mont L, Leal J, Garcia-Bolao I, Fernandez-Lozano I, Hernandez-Madrid A, Perez-Castellano N, Sitges M, Pavon-Jimenez R, Barba J, Cavero MA, Moya JL, Perez-Isla L, Brugada J; SCARS Investigators. Predictors of lack of response to resynchronization therapy. Am J Cardiol. 2005;95:1436-1440.
12. Molhoek SG, Bax JJ, Bleeker GB, Boersma E, van Erven L, Steendijk P, van der Wall EE. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiol. 2004;94:1506-1509.
13. Molhoek SG, Bax JJ, Boersma E, Van Erven L, Bootsma M, Steendijk P, Van Der Wall EE, Schalij MJ. QRS duration and shortening to predict clinical response to cardiac resynchronization therapy in patients with end-stage heart failure. Pacing Clin Electrophysiol. 2004;27:308-313.
14. Molhoek SG, Bax JJ, van Erven L, Bootsma M, Boersma E, Steendijk P, van der Wall EE, Schalij MJ. Comparison of benefits from cardiac resynchroni-zation therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy. Am J Cardiol. 2004;93:860-863.
15. Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, van der Wall EE, Schalij MJ. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44:1834-1840.
16. Bleeker GB, Kaandorp TAM, Lamb HJ, Boersma E, Steendijk P, de Roos A, van der Wall EE, Schalij MJ, Bax JJ. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resyn-chronization therapy. Circulation. 2006;113:969-976.
17. Ypenburg C, Schalij MJ, Bleeker GB, Steendijk P, Boersma E, Dibbets-Schneider P, Stokkel MPM, van der Wall EE, Bax JJ. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J. 2007;28:33-41.
18. White JA, Yee R, Yuan XP, Krahn A, Skanes A, Parker M, Klein G, Drangova M. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraven-tricular dyssynchrony. J Am Coll Cardiol. 2006;48:1953-1960.
19. Thomson Reuters. Web of Science, Science Citation Index Expanded database; ISI Web of Knowledge. Available at: http://apps.isiknowledge. com. Available at: http://apps.isiknowledge.com. Accessed June 15, 2009.
20. Bleeker GB, Mollema SA, Holman ER, Van De Veire N, Ypenburg C, Boersma E, van der Wall EE, Schalij MJ, Bax JJ. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline. Circulation. 2007;116:1440-1448.
21. Dohi K, Suffoletto MS, Schwartzman D, Ganz L, Pinsky MR, Gorcsan J. Utility of echocardiographic radial strain imaging to quantify left ventricular dyssynchrony and predict acute response to cardiac resynchroni-zation therapy. Am J Cardiol. 2005;96:112-116.
22. Gorcsan J, Kanzaki H, Bazaz R, Dohi K, Schwartzman D. Usefulness of echocardiographic tissue synchronization imaging to predict acute response to cardiac resynchronization therapy. Am J Cardiol. 2004;93:1178-1181.
23. Henneman MM, Chen J, Dibbets-Schneider P, Stokkel MR, Bleeker GB, Ypenburg C, van der Wall EE, Schalij MJ, Garcia EV, Bax JJ. Can LV dyssynchrony as assessed with phase analysis on gated myocardial perfusion SPECT predict response to CRT? J Nucl Med. 2007;48:1104-1111.
24. Lecoq G, Leclercq C, Leray E, Crocq C, Alonso C, de Place C, Mabo P, Daubert C. Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure. Eur Heart J. 2005;26:1094-1100.
25. Marcus GM, Rose E, Viloria EM, Schafer J, De Marco T, Saxon LA, Foster E; VENTAK CHF/CONTAK-CD Biventricular Pacing Study Investigators. Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resyn-chronization therapy. J Am Coll Cardiol. 2005;46:2208-2214.
26. Stellbrink C, Breithardt OA, Franke A, Sack S, Bakker P, Auricchio A, Pochet T, Salo R, Kramer A, Spinelli J; CPI Guidant Congestive Heart Failure Research Group. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol. 2001;38:1957-1965.
27. Ypenburg C, Roes SD, Bleeker GB, Kaandorp TAM, de Roos A, Schalij MJ, van der Wall EE, Bax JJ. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchro-nization therapy. Am J Cardiol. 2007;99:657-660.
28. Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman TB. Designing Clinical Research: An Epidemiologic Approach. 2nd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001.
29. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: Wiley; 1981.
30. St John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR, Loh E, Kocovic DZ, Fisher WG, Ellestad M, Messenger J, Kruger K, Hilpisch KE, Hill MR. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation. 2003;107:1985-1990.
31. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J. 2006;27:1928-1932.
32. Anand IS, Florea VG, Fisher L. Surrogate end points in heart failure. J Am Coll Cardiol. 2002;39:1414-1421.
33. Packer M. Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail. 2001;7:176-182.
34. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.